Company Update - Glucotrack Inc will present an update on its Continuous Blood Glucose Monitor (CBGM) at the TechBio Showcase during Biotech Showcase 2025 [1] - The presentation will be given by Paul V Goode, President and CEO of Glucotrack [1] - The CBGM is a long-term implantable system with a sensor longevity of 3 years, no on-body wearable component, and minimal calibration [6] Event Details - The TechBio Showcase presentation will take place on Tuesday, January 14 at 9:30am PT in Yosemite C (Ballroom Level) [2] - TechBio Showcase is part of Biotech Showcase, an investor conference focused on therapeutic development and networking opportunities [2][4] - Biotech Showcase is in its 17th year and features multiple tracks of presenting companies, plenary sessions, workshops, and one-to-one meetings [4] Company Overview - Glucotrack Inc is a medical technology company focused on developing novel technologies for people with diabetes [5] - The company is currently developing a long-term implantable continuous blood glucose monitoring system [5] Additional Information - More details about Glucotrack's CBGM can be found on the company's website [3] - The TechBio Showcase is produced by Demy-Colton and EBD Group, organizations with a long history of supporting the biotechnology and life sciences industry [4]
Glucotrack to Present at TechBio Showcase™ 2025